Prediction of Complications in Hepatic Tumors

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Hepatic Tumors Interventions: Diagnostic Test: [99mTc] Tc-GSA SPECT/CT Sponsors: Rigshospitalet, Denmark; Danish Cancer Society Not yet recruiting Conditions: Hepatic Tumors Interventions: Diagnostic Test: [99mTc] Tc-GSA SPECT/CT Sponsors:...

Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Follicular Lymphoma (FL) Interventions: Biological: TC011 single-arm Sponsors: TICAROS Co., Ltd. Not yet recruiting Conditions: Follicular Lymphoma (FL) Interventions: Biological: TC011 single-arm Sponsors: TICAROS Co., Ltd. Not yet...

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Refractory Metastatic Colorectal Cancer Interventions: Drug: Suvemcitug injection, trifluridine/tipiracil tablets; Drug: Suvemcitug placebo injection, trifluridine/tipiracil tablets Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Jiangsu Simcere...

Viral Infections of the Central Nervous System: Diagnosis and Clinical Outcome

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Infection; Virus Disease; CNS Infection Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna Active, not recruiting Conditions: Infection; Virus Disease; CNS Infection Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna Active, not...

Partial Enteral Nutrition as Therapeutic Augmentation of Advanced Pharmacological Therapy in Patients With Active Crohn’s Disease

by palligoelme@gmail.com | Jan 21, 2026 | Clinical Trials

​ Conditions: Crohn’s Disease, Active Interventions: Dietary Supplement: Partial enteral nutrition – orally consumed formula Sponsors: University of Pennsylvania Not yet recruiting Conditions: Crohn’s Disease, Active Interventions: Dietary...

A Phase III, Randomized, Double-blind, Placebo-controlled Study to Confirm the AuthenTicity of Point of Care Urine samplEs Using Oral fluoreScein Sodium in adulTs With substancE Use Disorder

by palligoelme@gmail.com | Jan 21, 2026 | Clinical Trials

​ Conditions: Substance Use Disorder (SUD) Interventions: Drug: Fluorescein; Other: placebo Sponsors: UpTru Inc. Not yet recruiting Conditions: Substance Use Disorder (SUD) Interventions: Drug: Fluorescein; Other: placebo Sponsors: UpTru Inc. Not yet...